Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 8, 2021
Refractory and Resistant Cytomegalovirus After Hematopoietic Cell Transplant in the Letermovir Primary Prophylaxis EraJoseph Sassine, Fareed Khawaja, Terri Lynn Shigle, et al.
Blood|November 28, 2014
Ex vivo fucosylation of third-party human regulatory T cells enhances anti-graft-versus-host disease potency in vivoSimrit Parmar, Xiaoying Liu, Amer Najjar, et al.
American Journal of Hematology|January 11, 2012
BCR-ABL1 kinase domain mutations: methodology and clinical evaluationMary Alikian, Gareth Gerrard, Papagudi G Subramanian, et al.
The Journal of Infectious Diseases|February 25, 2016
Utility of the Enzyme-Linked Immunospot Interferon-γ-Release Assay to Predict the Risk of Cytomegalovirus Infection in Hematopoietic Cell Transplant RecipientsLior Nesher, Dimpy P Shah, Ella J Ariza-Heredia, et al.
The Journal of Infectious Diseases|October 9, 2018
The Ability of a Cytomegalovirus ELISPOT Assay to Predict Outcome of Low-Level CMV Reactivation in Hematopoietic Cell Transplant RecipientsLynn El Haddad, Ella Ariza-Heredia, Dimpy P Shah, et al.
Haematologica|April 21, 2009
The level of BCR-ABL1 kinase activity before treatment does not identify chronic myeloid leukemia patients who fail to achieve a complete cytogenetic response on imatinibJamshid Sorouri Khorashad, Simon Wagner, Liat Greener, et al.
Cancer|February 27, 2020
Significance of minimal residual disease monitoring by real-time quantitative polymerase chain reaction in core binding factor acute myeloid leukemia for transplantation outcomesFevzi F Yalniz, Keyur P Patel, Qaiser Bashir, et al.
Blood|February 29, 2012
Graft invariant natural killer T-cell dose predicts risk of acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantationAristeidis Chaidos, Scott Patterson, Richard Szydlo, et al.
Cancer|March 22, 2017
Cytogenetics and comorbidity predict outcomes in older myelodysplastic syndrome patients after allogeneic stem cell transplantation using reduced intensity conditioningOrhan Kemal Yucel, Rima M Saliba, Gabriella Rondon, et al.
Haematologica|October 17, 2009
Early prediction of success or failure of treatment with second-generation tyrosine kinase inhibitors in patients with chronic myeloid leukemiaDragana Milojkovic, Emma Nicholson, Jane F Apperley, et al.
Pageof 4